Other Information.
−Removed: Rule 10b5-1 Trading Arrangements
−Removed: On August 27, 2024 , Sean McCarthy , CEO , adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 200,000 shares of the Company’s common stock until December 31, 2025 .
−Removed: CytomX Therapeutics, Inc.
Incorporated by Reference
4 unchanged sentences
Specimen Common Stock Certificate
−Removed: Amendment No.
−Removed: 2 to Open Market Sales Agreement, dated as of August 9, 2024, by and between CytomX Therapeutics, Inc.
−Removed: and Jefferies LLC.
−Removed: Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
−Removed: Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).
+Added: Separation Agreement, dated January 30, 2025, by and between CytomX Therapeutics, Inc.
+Added: and Jeffrey Landau.
+Added: Certification of Chief Executive Principal required by Rule 13a-14(a) or Rule 15d-14(a).
+Added: Certification of Chief Financial Principal required by Rule 13a-14(a) or Rule 15d-14(a).
Certification of Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C.
9 unchanged sentences
under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.
−Removed: CytomX Therapeutics, Inc.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CytomX Therapeutics, Inc.
−Removed: November 7, 2024
Chief Executive Officer and Chairman
(Principal Executive Officer)
−Removed: November 7, 2024
/s/ Christopher W.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.